DOH seeks FDA approval for 4th COVID-19 vaccine dose

The Department of Health (DOH) has applied to the Food and Drug Administration (FDA) for an amended emergency use authorization (EUA) to include a fourth dose of COVID-19 vaccines for senior citizens and immunocompromised individuals.

Health Undersecretary Maria Rosario Vergeire stated that the DOH is awaiting FDA's decision before discussing possible implementation.

Vaccine Expert Panel (VEP) member Dr. Rontgene Solante noted that a fourth dose may only be necessary for elderly and immunocompromised groups, not younger populations.

This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.

Topics in this story

Explore more stories about these topics